1. Home
  2. SNGX vs OP Comparison

SNGX vs OP Comparison

Compare SNGX & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • OP
  • Stock Information
  • Founded
  • SNGX 1987
  • OP 2021
  • Country
  • SNGX United States
  • OP Greece
  • Employees
  • SNGX N/A
  • OP N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • OP
  • Sector
  • SNGX Health Care
  • OP
  • Exchange
  • SNGX Nasdaq
  • OP Nasdaq
  • Market Cap
  • SNGX 7.4M
  • OP 8.5M
  • IPO Year
  • SNGX 1987
  • OP N/A
  • Fundamental
  • Price
  • SNGX $2.39
  • OP $1.11
  • Analyst Decision
  • SNGX
  • OP
  • Analyst Count
  • SNGX 0
  • OP 0
  • Target Price
  • SNGX N/A
  • OP N/A
  • AVG Volume (30 Days)
  • SNGX 44.9K
  • OP 11.3K
  • Earning Date
  • SNGX 03-14-2025
  • OP 04-10-2025
  • Dividend Yield
  • SNGX N/A
  • OP N/A
  • EPS Growth
  • SNGX N/A
  • OP N/A
  • EPS
  • SNGX N/A
  • OP N/A
  • Revenue
  • SNGX $364,183.00
  • OP $25,729,000.00
  • Revenue This Year
  • SNGX N/A
  • OP N/A
  • Revenue Next Year
  • SNGX $76.64
  • OP N/A
  • P/E Ratio
  • SNGX N/A
  • OP N/A
  • Revenue Growth
  • SNGX N/A
  • OP 36.33
  • 52 Week Low
  • SNGX $1.83
  • OP $1.02
  • 52 Week High
  • SNGX $14.88
  • OP $3.15
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 43.83
  • OP 39.14
  • Support Level
  • SNGX $2.25
  • OP $1.11
  • Resistance Level
  • SNGX $2.60
  • OP $1.18
  • Average True Range (ATR)
  • SNGX 0.15
  • OP 0.04
  • MACD
  • SNGX 0.03
  • OP 0.00
  • Stochastic Oscillator
  • SNGX 52.27
  • OP 3.50

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.

Share on Social Networks: